The pathogen Clostridioides difficile (C. difficile) is naturally present in the intestines of many people. When present in ...

A retrospective Chinese cohort study finds that serial changes in PCR cycle threshold values for the tcdB gene correlate with ...

Three scientific presentations will highlight new analyses of VOQUEZNA® (vonoprazan) in GERD, including real-world patient characteristics, ...

A new review in Gut Pathogens argues that SARS-CoV-2 infection and COVID-19 care pathways may create gut conditions ...

In a new study, researchers modeled the transmission of Clostridioides difficile (C. diff) infections among patients in ...

All of the patients in the study were on antibiotics at one point during the study, and many received broad-spectrum ...

In a new study, researchers modeled the transmission of Clostridioides difficile (C. diff) infections among patients in hospital cancer units.

Acurx Pharmaceuticals (ISIN US00510M2035) remains tied to a USD 10.00 analyst target after Stock Analysis reported on ...

Overview The Global Infection Surveillance Solutions Market size is expected to be worth around US$ 2.9 Billion by 2034 from US$ 0.8 Billion in 2024, growing at a CAGR of 13.6% during the forecast ...

In a new study, researchers modeled the transmission of Clostridioides difficile (C. diff) infections among patients in hospital cancer units. They ...

For patients with a first episode or first recurrence of Clostridioides difficile infection (CDI), a 4-week vancomycin pulse and taper regimen showed a 73.8% probability of being superior to a ...

In a new study, researchers modeled the transmission of Clostridioides difficile (C. diff) infections among patients in ...